Sort
64,565 grants matching “drug discovery”
Novel therapeutics for fatty liver disease and type-II diabetes
$909,785Dave Musso · Southeast Techinventures, Inc. · R44 · FY2014 · DK
Functional Analysis of Oncogenic Networks in Primary Organoids
$909,785Calvin J Kuo · Stanford University · U01 · FY2016 · CA
SBIR Phase II: New ingredients technology to enhance the safety, quality, and value of active substances for pharmaceuticals, food, and personal care
$909,741Henry Havel · Phytoption Llc · · FY2016 · TIP
Tackling Undruggable Cancer Targets using Chemoproteomic Platforms
$909,665Daniel Nomura · University Of California Berkeley · R35 · FY2023 · CA
From Academia to Business: Development of Novel Therapeutics Against HPV-Associated Cancer
$909,657Anne Rietz · Kovina Therapeutics Inc. · R44 · FY2023 · CA
Identification and characterization of novel drugs that target the Influenza
$909,621Richard J. Whitley · University Of Alabama At Birmingham · U19 · FY2015 · AI
Molecular strategies for early detection and targeting of cancer
$909,506Tannishtha Reya · University Of California, San Diego · R35 · FY2017 · CA
Regulatory T Cells in Autoimmune Disease
$909,305David A. Hafler · Brigham And Women'S Hospital · U19 · FY2008 · AI
Small Molecule Inhibitors of PCSK9-Phase II
$909,169Salim Shah · Hingez Therapeutics, Inc. · R44 · FY2018 · HL
Small Molecule Inhibitors of PCSK9-Phase II
$909,169Salim Shah · Hingez Therapeutics, Inc. · R44 · FY2019 · HL
Synthesis of Non-GMP Small Molecules
$909,000Mary Tanga · Sri International · N02 · FY2010 · CA
Host and viral genomic determinants of HIV latent reservoir size and characteristics in individuals with substance use disorders
$908,958Robert F Siliciano · Johns Hopkins University · R61 · FY2019 · DA
NRF Transcription Factors in Environmental Stress and Disease Intervention
$908,897Donna D Zhang · University Of Arizona · R35 · FY2023 · ES
3D Bioprinted skin models for drug screening
$908,895Marc Ferrer · National Center For Advancing Translational Sciences · ZIA · FY2022 · TR
3D Bioprinted lung cancer models for drug screening
$908,895Marc Ferrer · National Center For Advancing Translational Sciences · ZIA · FY2022 · TR
3D Bioprinted Omentum tissue to model ovarian cancer metastasis
$908,894Marc Ferrer · National Center For Advancing Translational Sciences · ZIA · FY2022 · TR
Bioinformatics and Computational Biology Core
$908,711Kun Huang · Indiana University Indianapolis · U54 · FY2022 · AG
Bioinformatics and Computational Biology Core
$908,711Kun Huang · Indiana University Indianapolis · U54 · FY2023 · AG
The Neuroproteomics and Neurometabolomics Center on Cell-Cell Signaling
$908,664Jonathan V. Sweedler · University Of Illinois At Urbana-Champaign · P30 · FY2016 · DA
Development of Sudaxine for the Treatment of Opioid Induced Respiratory Depression (OIRD) in the Peri-operative Hospital Setting
$908,519James N Bates · Atelerix Life Sciences Inc. · R44 · FY2022 · HL
Identifying driver mutations and tumor dependencies by comparative oncogenomics.
$907,845Scott W Lowe · Cold Spring Harbor Laboratory · U01 · FY2012 · CA
Transporter function of the Mycobacterium tuberculosis PE/PPE proteins
$907,773Christoph Grundner · Seattle Children'S Hospital · R01 · FY2024 · AI
Systems Biology based Proteogenomic Translator for Cancer Marker Discovery towards Precision Medicine
$907,614Pei Wang · Icahn School Of Medicine At Mount Sinai · U24 · FY2020 · CA
Ceramides as novel drivers of metabolic dysfunction and colorectal cancer
$907,536Mary Christine Playdon · University Of Utah · U01 · FY2024 · CA
Discovery of potent and selective neuropeptide Y Y2 receptor antagonist probes
$907,100Thomas D Bannister · Scripps Research Institute, The · U01 · FY2010 · AA